 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/19/2023 |
$72.35 |
$73.87 |
$72.16 |
$73.75 |
9.39M | | 01/20/2023 |
$73.90 |
$74.15 |
$73.35 |
$74.15 |
10.52M | | 01/23/2023 |
$74.09 |
$74.20 |
$72.85 |
$73.26 |
7.43M | | 01/24/2023 |
$73.00 |
$75.00 |
$72.12 |
$72.34 |
7.30M | | 01/25/2023 |
$72.56 |
$73.24 |
$72.01 |
$73.17 |
6.64M |
|
|
| Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s primary products include: Revlimid®, in which Revlimid (lenalidomide) is an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma; and Eliquis®, in which Eliquis (apixaban) is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy. | |
|
Bristol Myers Squibb (BMY) has the following price history information. Looking back at BMY historical stock prices for the last five trading days, on January 19, 2023, BMY opened at $72.35, traded as high as $73.87 and as low as $72.16, and closed at $73.75. Trading volume was a total of 9.39M shares. On January 20, 2023, BMY opened at $73.90, traded as high as $74.15 and as low as $73.35, and closed at $74.15. Trading volume was a total of 10.52M shares. On January 23, 2023, BMY opened at $74.09, traded as high as $74.20 and as low as $72.85, and closed at $73.26. Trading volume was a total of 7.43M shares. On January 24, 2023, BMY opened at $73.00, traded as high as $75.00 and as low as $72.12, and closed at $72.34. Trading volume was a total of 7.30M shares. On January 25, 2023, BMY opened at $72.56, traded as high as $73.24 and as low as $72.01, and closed at $73.17. Trading volume was a total of 6.64M shares.
BMY Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bristol Myers Squibb shares, starting with a $10,000 purchase of BMY, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/29/2013 |
|
| End date: |
01/25/2023 |
|
| Start price/share: |
$36.54 |
|
| End price/share: |
$73.17 |
|
| Starting shares: |
273.67 |
|
| Ending shares: |
364.83 |
|
| Dividends reinvested/share: |
$16.78 |
|
| Total return: |
166.94% |
|
| Average Annual Total Return: |
10.32% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$26,687.56 |
|
| Years: |
9.99 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/29/2013 |
|
| End date: |
01/25/2023 |
|
| Start price/share: |
$36.54 |
|
| End price/share: |
$73.17 |
|
| Dividends collected/share: |
$16.78 |
|
| Total return: |
146.17% |
|
| Average Annual Total Return: |
9.43% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$24,612.15 |
|
| Years: |
9.99 |
|
|
|
| Date |
Close |
| 01/19/2023 | $73.75 | | 01/20/2023 | $74.15 | | 01/23/2023 | $73.26 | | 01/24/2023 | $72.34 | | 01/25/2023 | $73.17 |
|
|
Free BMY Email Alerts:
